Paper24672200
Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.
Deka P and 5 others. J Midlife Health, 2014. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study. Papers, record 24672200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24672200
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7774836 | The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. | Gynecol Oncol | 1995 | https://conductscience.org/library/papers/7774836 | PubMed |
| 2 | 17161169 | Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. | Int J Gynaecol Obstet | 2006 | https://conductscience.org/library/papers/17161169 | PubMed |
| 3 | 20153883 | Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease? | Gynecol Oncol | 2010 | https://conductscience.org/library/papers/20153883 | PubMed |
| 4 | 19331201 | Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. | Anticancer Res | 2009 | https://conductscience.org/library/papers/19331201 | PubMed |
| 5 | 19367689 | Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. | Int J Gynaecol Obstet | 2009 | https://conductscience.org/library/papers/19367689 | PubMed |
| 6 | 2014852 | Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). | Am J Obstet Gynecol | 1991 | https://conductscience.org/library/papers/2014852 | PubMed |
| 7 | 6488136 | Preoperative radiation therapy for locally advanced vulvar cancer. | Cancer | 1984 | https://conductscience.org/library/papers/6488136 | PubMed |
| 8 | 3972295 | Prognostic factors in carcinoma of the vulva. | Gynecol Oncol | 1985 | https://conductscience.org/library/papers/3972295 | PubMed |
| 9 | 22266935 | Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. | Int J Gynecol Cancer | 2012 | https://conductscience.org/library/papers/22266935 | PubMed |
| 10 | 11803102 | Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. | Eur J Obstet Gynecol Reprod Biol | 2002 | https://conductscience.org/library/papers/11803102 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42038989 | Temporal Trends in Vulvar Cancer Cases and Associated Factors of Adverse Clinical Features: A 6-year Retrospective Study From a Tertiary Hospital in Indonesia. | Int J Womens Health | 2026 | https://conductscience.org/library/papers/42038989 | PubMed |
| 41561673 | Systemic inflammation indices and serum squamous cell carcinoma (SCC) antigen: an exploratory analysis on prognosis of patients with vulvar squamous cell carcinoma. | Gynecol Oncol Rep | 2026 | https://conductscience.org/library/papers/41561673 | PubMed |
| 40207260 | Vascular segmental exclusion for recurrent vulvar squamous cell carcinoma invading the femoral vessels. | J Vasc Surg Cases Innov Tech | 2025 | https://conductscience.org/library/papers/40207260 | PubMed |
| 39758564 | Survival Trends Following Surgical Management in Carcinoma Vulva Patients During Covid 19 Pandemic: A Tertiary Care Hospital Study. | J Obstet Gynaecol India | 2024 | https://conductscience.org/library/papers/39758564 | PubMed |
| 39695681 | Patterns of care for vulvar cancer and insights from revised FIGO staging: a retrospective study. | World J Surg Oncol | 2024 | https://conductscience.org/library/papers/39695681 | PubMed |
| 36417690 | The Unmet Needs in the Management of Vulvar Cancer and a Review of Indian Literature. | JCO Glob Oncol | 2022 | https://conductscience.org/library/papers/36417690 | PubMed |
| 34452569 | Clinicopathological Prognostic Factors Influencing Survival Outcomes of Vulvar Cancer. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/34452569 | PubMed |
| 31844370 | An Overview of Vulvar Cancer: A Single-Center Study from Northeast India. | J Obstet Gynaecol India | 2019 | https://conductscience.org/library/papers/31844370 | PubMed |
| 25930015 | Vulvar cancer: a review for dermatologists. | Wien Med Wochenschr | 2015 | https://conductscience.org/library/papers/25930015 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24672200
GET https://conductscience.org/api/papers/v1/24672200/authors